文献速递临床试验与 GCP流行病学与生物统计

协作共享照护改善精神病结局(COSIMPO):一项随机对照试验的研究方案

COllaborative Shared care to IMprove Psychosis Outcome (COSIMPO): study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2017-10-10

COSIMPO是一项在尼日利亚和加纳开展的单盲、整群随机对照试验,比较由补充替代卫生服务提供者(CAP)与初级卫生保健提供者(PHCP)实施的协作共享照护(CSC)与常规照护(CAU)对精神病患者结局的效果。研究计划从51个整群中招募约296名参与者,主要结局为入组6个月时阳性与阴性症状量表(PANSS)的改善。

要点

  • COSIMPO为单盲整群随机对照试验,在尼日利亚和加纳比较CSC与CAU对精神病患者结局的效果。
  • 计划从51个整群中招募约296名参与者,每个整群由一家初级保健诊所及其邻近CAP机构组成。
  • 主要结局为入组6个月时PANSS改善,次要结局在3个月和6个月评估。

核心结论

  • 研究旨在检验接受CSC的患者在入组6个月时临床结局优于接受CAU的患者,且经历CAP有害治疗实践更少。
  • 关于正统与补充卫生服务提供者协作是否可行及能否改善患者结局的信息,对制定将传统和信仰治疗者正式纳入公共卫生系统的政策很重要。

研究设计与样本

  • COSIMPO是一项在尼日利亚和加纳开展的单盲、整群随机对照试验。
  • 计划从51个整群中招募约296名参与者,每个整群由一家初级保健诊所及其邻近CAP机构组成。
  • CSC为手册化干预方案,包括PHCP定期按计划访问CAP机构以协助试验参与者管理。
  • 协助内容包括给予抗精神病药物、管理共病躯体状况、协助CAP避免有害治疗实践,以及与CAP、照护者和参与者共同规划出院和康复。

主要发现

  • 主要结局为入组6个月时阳性与阴性症状量表(PANSS)的改善。
  • 次要结局在3个月和6个月评估,包括残疾水平、有害治疗实践和受害经历、感知病耻感水平及照护者负担水平。

关键数值与推荐

  • 试验注册:美国国立卫生研究院临床试验注册库,ID:NCT02895269,注册日期2016年7月30日。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Psychotic disorders are a group of severe mental disorders that cause considerable disability to sufferers and a high level of burden to families. In many low- and middle-income countries (LMIC), traditional and faith healers are the main providers of care to affected persons. Even though frequently canvassed as desirable for improved care delivery, collaboration between these complementary alternative health providers (CAPs) and conventional health providers has yet to be rigorously tested for feasibility and effectiveness on patient outcomes. METHODS/DESIGN: COSIMPO is a single-blind, cluster randomized controlled trial (RCT) being conducted in Nigeria and Ghana to compare the effectiveness of a collaborative shared care (CSC) intervention program implemented by CAPs and primary health care providers (PHCPs) with care as usual (CAU) at improving the outcome of patients with psychosis. The study is designed to test the hypotheses that patients receiving CSC will have a better clinical outcome and experience fewer harmful treatment practices from the CAPs than patients receiving CAU at 6 months after study entry. An estimated sample of 296 participants will be recruited from across 51 clusters, with a cluster consisting of a primary care clinic and its neighboring CAP facilities. CSC is a manualized intervention package consisting of regular and scheduled visits of PHCPs to CAP facilities to assist with the management of trial participants. Assistance includes the administration of antipsychotic medications, management of comorbid physical condition, assisting the CAP to avoid harmful treatment practices, and engaging with CAPs, caregivers and participants in planning discharge and rehabilitation. The primary outcome, assessed at 6 months following trial entry, is improvement on the Positive and Negative Symptom Scale (PANSS). Secondary outcomes, assessed at 3 and 6 months, consist of levels of disability, experience of harmful treatment practices and of victimization, and levels of perceived stigma and of caregivers' burden. DISCUSSION: Information about whether collaboration between orthodox and complementary health providers is feasible and can lead to improved outcome for patients is important to formulating policies designed to formally engage the services of traditional and faith healers within the public health system. TRIAL REGISTRATION: National Institutes of Health Clinical Trial registry, ID: NCT02895269 . Registered on 30 July 2016.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Gureje O, Makanjuola V, Kola L, et al. COllaborative Shared care to IMprove Psychosis Outcome (COSIMPO): study protocol for a randomized controlled trial. Trials. 2017. PMID: 29017605. doi:10.1186/s13063-017-2187-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。